Novartis
NVS
NVS
815 hedge funds and large institutions have $19.8B invested in Novartis in 2013 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 286 increasing their positions, 285 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more repeat investments, than reductions
Existing positions increased: 286 | Existing positions reduced: 285
0.09% more ownership
Funds ownership: 9.91% → 9.99% (+0.09%)
5% less funds holding in top 10
Funds holding in top 10: 55 → 52 (-3)
Holders
815
Holding in Top 10
52
Calls
$182M
Puts
$134M
Top Buyers
| 1 | +$185M | |
| 2 | +$182M | |
| 3 | +$61.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$58.5M |
| 5 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$44.4M |
Top Sellers
| 1 | -$142M | |
| 2 | -$74.7M | |
| 3 | -$69.8M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$44.6M |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$43.8M |